Related references
Note: Only part of the references are listed.Application of physiologically based pharmacokinetic modelling for the prediction of drug-drug interactions involving anlotinib as a perpetrator of cytochrome P450 enzymes
Zhiping Jin et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2022)
Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling
Size Li et al.
ARCHIVES OF TOXICOLOGY (2021)
Contribution of preclinical MRI to responsible animal research: living up to the 3R principle
Lydia Wachsmuth et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2021)
Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018-2019 Submissions to the US FDA's Office of Clinical Pharmacology
Xinyuan Zhang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein
Jiaxin Pi et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Physiologically Based Pharmacokinetic Modelling for First-In-Human Predictions: An Updated Model Building Strategy Illustrated with Challenging Industry Case Studies
Neil A. Miller et al.
CLINICAL PHARMACOKINETICS (2019)
Corneal-PAMPA: A novel, non-cell-based assay for prediction of corneal drug permeability
Gergo Dargo et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
A translational platform PBPK model for antibody disposition in the brain
Hsueh-Yuan Chang et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2019)
PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol
Huybrecht T'jollyn et al.
AAPS JOURNAL (2019)
An Estimate of the Number of Animals Used for Scientific Purposes Worldwide in 2015
Katy Taylor et al.
ATLA-ALTERNATIVES TO LABORATORY ANIMALS (2019)
Pediatric Dose Selection and Utility of PBPK in Determining Dose
Ian E. Templeton et al.
AAPS JOURNAL (2018)
Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation
Corie A. Ellison
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
A Permeability-Limited Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctanoic acid (PFOA) in Male Rats
Weixiao Cheng et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2017)
In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development
Franco Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Influences of Anlotinib on Cytochrome P450 Enzymes in Rats Using a Cocktail Method
Wei Sun et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Gastrointestinal behavior and ADME phenomena: I. In vitro simulation
Sara Cascone et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2016)
Simultaneous determination of bupropion, metroprolol, midazolam, phenacetin, omeprazole and tolbutamide in rat plasma by UPLC-MS/MS and its application to cytochrome P450 activity study in rats
Jianshe Ma et al.
BIOMEDICAL CHROMATOGRAPHY (2015)
Comparing translational population-PBPK modelling of brain microdialysis with bottom-up prediction of brain-to-plasma distribution in rat and human
Kathryn Ball et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2014)
PBPK models for the prediction of in vivo performance of oral dosage forms
Edmund S. Kostewicz et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Evaluation of the effect of apatinib (YN968D1) on cytochrome P450 enzymes with cocktail probe drugs in rats by UPLC-MS/MS
Yunfang Zhou et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2014)
Baicalein-Nicotinamide Cocrystal with Enhanced Solubility, Dissolution, and Oral Bioavailability
Yanting Huang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Da-Chaihu-Tang alters the pharmacokinetics of nifedipine in rats and a treatment regimen to avoid this
Ju-Xiu He et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2014)
The Effects of Acute Hydrogen Sulfide Poisoning on Cytochrome P450 Isoforms Activity in Rats
Xianqin Wang et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The Utility of Modeling and Simulation in Drug Development and Regulatory Review
Shiew-Mei Huang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Pharmacokinetics, pharmacodynamics and toxicity of a combination of metoprolol succinate and telmisartan in Wistar albino rats: Safety profiling
Utpal Nandi et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2013)
Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment
M. E. (Bette) Meek et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2013)
Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies
Yuan Chen et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2012)
Pharmacokinetic and pharmacodynamic interaction between nifedipine and metformin in rats: competitive inhibition for metabolism of nifedipine and metformin by each other via CYP isozymes
Young H. Choi et al.
XENOBIOTICA (2012)
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Malcolm Rowland et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Prediction of Oral Pharmacokinetics of cMet Kinase Inhibitors in Humans: Physiologically Based Pharmacokinetic Model Versus Traditional One-Compartment Model
Shinji Yamazaki et al.
DRUG METABOLISM AND DISPOSITION (2011)
Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal
Jianjun Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Effect of Diallyl Trisulfide on the Pharmacokinetics of Nifedipine in Rats
Yue Wang et al.
JOURNAL OF FOOD SCIENCE (2011)
The contribution of dermal exposure to the internal exposure of bisphenol A in man
H. Mielke et al.
TOXICOLOGY LETTERS (2011)
Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol
In-Soo Yoon et al.
XENOBIOTICA (2011)
Effect of soybean administration on the pharmacokinetics of carbamazepine and omeprazole in rats
Dharmender Singh et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2010)
In silico methods for physiologically based biokinetic models describing bioactivation and detoxification of coumarin and estragole: Implications for risk assessment
Ivonne M. C. M. Rietjens et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Faster Clearance of Omeprazole in Mutant Nagase Analbuminemic Rats: Possible Roles of Increased Protein Expression of Hepatic CYP1A2 and Lower Plasma Protein Binding
Dae Y. Lee et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2009)
The 3R principle and the use of non-human primates in the study of neurodegenerative diseases: The case of Parkinson's disease
Augusto Vitale et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)
Bisphenol A levels in blood depend on age and exposure
Hans Mielke et al.
TOXICOLOGY LETTERS (2009)
Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus
Choong Y. Ahn et al.
DRUG METABOLISM AND DISPOSITION (2008)
Development and specification of physiologically based pharmacokinetic models for use in risk assessment
Rebecca A. Clewell et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2008)
Effects of Sairei-to on the pharmacokinetics of nifedipine in rats
Mika Ikehata et al.
PHYTOTHERAPY RESEARCH (2008)
Pharmacokinetic interaction between oltipraz and omeprazole in rats: Competitive inhibition of metabolism of oltipraz by omeprazole via CYP1A1 and 3A2, and of omeprazole by oltipraz via CYP1A1/2, 2D1/2, and 3A1/2
Dae Y. Lee et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
In vitro methods to study intestinal drug metabolism
Esther G. van de Kerkhof et al.
CURRENT DRUG METABOLISM (2007)
In vitro-in vivo extrapolation of hepatic clearance:: Biological tools, scaling factors, model assumptions and correct concentrations
O. Pelkonen et al.
XENOBIOTICA (2007)
Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs
Stefan S. De Buck et al.
DRUG METABOLISM AND DISPOSITION (2007)
Mechanistic approaches to volume of distribution predictions: Understanding the processes
Trudy Rodgers et al.
PHARMACEUTICAL RESEARCH (2007)
Pharmacokinetics of omeprazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine
Dae Y. Lee et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
Amin Rostami-Hodjegan et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Effects of cysteine on the pharmacokinetic parameters of omeprazole in rats with protein-calorie malnutrition: Partial restoration of some parameters to control levels by oral cysteine supplementation
Dae Y. Lee et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2007)
Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation
Hye W. Baek et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Pharmacokinetics of omeprazole in rats with water deprivation for 72 hours
Dae Y. Lee et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2006)
Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model
Xianhua Cao et al.
PHARMACEUTICAL RESEARCH (2006)
Determination of omeprazole in rat plasma by high-performance liquid chromatography without solvent extraction
Huijuan Jia et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
In vitro methods in human drug biotransformation research: Implications for cancer chemotherapy
N Hariparsad et al.
TOXICOLOGY IN VITRO (2006)
Tissue distribution of basic drugs:: Accounting for enantiomeric, compound and regional differences amongst β-blocking drugs in rat
T Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Pharmacokinetics and metabolism of metoprolol and propranolol in the female DA and female Wistar rat: The female DA rat is not always an animal model for poor metabolizers of CYP2D6
H Komura et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination
LM Berezhkovskiy
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
In vitro methods in the prediction of kinetics of drugs:: Focus on drug metabolism
H Raunio et al.
ATLA-ALTERNATIVES TO LABORATORY ANIMALS (2004)
Whole body pharmacokinetic models
I Nestorov
CLINICAL PHARMACOKINETICS (2003)
Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution
P Poulin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures
S Haddad et al.
TOXICOLOGICAL SCIENCES (2001)
Progress in predicting human ADME parameters in silico
S Ekins et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Share Paper
